Alnylam Outlines 2016 Goals for RNAi Therapeutics Pipeline
Go back to Alnylam Outlines 2016 Goals for RNAi Therapeutics Pipeline| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 221.20 +4.22 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.98 | 52 Week High | $109.10 | |||
| Open | $217.41 | 52 Week Low | $31.38 | |||
| Day High | $223.44 | P/E | N/A | |||
| Day Low | $216.50 | EPS | $-1.45 | |||
| Volume | 1,439,998 | |||||
| Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 18.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.83 | 52 Week High | $18.64 | |||
| Open | $18.88 | 52 Week Low | $12.59 | |||
| Day High | $18.89 | P/E | N/A | |||
| Day Low | $18.80 | EPS | $0.00 | |||
| Volume | 13,411 | |||||
